Lakshmi Kotra

Prof. Lakshmi Kotra

Leslie Dan Faculty of Pharmacy, University of Toronto, and Krembil Research Institute, University Health Network, Toronto, Ontario, Canada
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2001 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SKSteven J. Kridel
Steven J. Kridel
ECEmily Chen
Emily Chen
Lakshmi KotraLakshmi Kotra
Lakshmi Kotra
EHEric W. Howard
Eric W. Howard
SMShahriar Mobashery
Shahriar Mobashery
JSJeffrey W. Smith
Jeffrey W. Smith
The catalytic clefts of all matrix metalloproteinases (MMPs) have a similar architecture, raising questions about the redundancy in substrate recognition across the protein family. In the present study, an unbiased phage display strategy was applied to define the substrate recognition profile of MMP-9. Three groups of substrates were identified, each occupying a distinct set of subsites within the catalytic pocket. The most prevalent motif contains the sequence Pro-X-X-Hy-(Ser/Thr) at P3 through P2′. This sequence is similar to the MMP cleavage sites within the collagens and is homologous to substrates the have been selected for other MMPs. Despite this similarity, most of the substrates identified here are selective for MMP-9 over MMP-7 and MMP-13. This observation indicates that substrate selectivity is conferred by key subsite interactions at positions other than P3 and P1′. This study shows that MMP-9 has a unique preference for Arg at both P2 and P1, and a preference for Ser/Thr at P2′. Substrates containing the consensus MMP-9 recognition motif were used to query the protein data bases. A surprisingly limited list of putative physiologic substrates was identified. The functional implications of these proteins lead to testable hypotheses regarding physiologic substrates for MMP-9.

6 March 2002 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JHJalal Haddad
Jalal Haddad
Lakshmi KotraLakshmi Kotra
Lakshmi Kotra
BLBeatriz Llano-Sotelo
Beatriz Llano-Sotelo
CKChoonkeun Kim
Choonkeun Kim
EAEduardo F. Azucena
Eduardo F. Azucena
SMShahriar Mobashery
Shahriar Mobashery

1 April 2002 in Chemistry & Biology
Verified
Journal Article
Closed access
BLBeatriz Llano-Sotelo
Beatriz Llano-Sotelo
EAEduardo F. Azucena
Eduardo F. Azucena
Lakshmi KotraLakshmi Kotra
Lakshmi Kotra
SMShahriar Mobashery
Shahriar Mobashery
CCChristine S. Chow
Christine S. Chow

1 July 2002 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MTMarta Toth
Marta Toth
SHSonia Hernandez-Barrantes
Sonia Hernandez-Barrantes
POPamela Osenkowski
Pamela Osenkowski
MBM. Margarida Bernardo
M. Margarida Bernardo
DGDavid C. Gervasi
David C. Gervasi
RFRafael Fridman
Rafael Fridman
Inwardly rectifying K+ channels or Kirs are a large gene family and have been predicted to have two transmembrane segments, M1 and M2, intracellular N and C termini, and two extracellular loops, E1 and E2, separated by an intramembranous pore-forming segment, H5. H5 contains a stretch of eight residues that are similar in voltage-dependent K+ channels, Kvs, and this stretch is called the signature sequence of K+ channels. Because mutations in this sequence altered selectivity in Kvs, it has been designated as the selectivity filter. Previously, we used N-glycosylation substitution mutants to map the extracellular topology of a weak inwardly rectifying K+ channel, Kir1.1 or ROMK1, and found that the entire H5 segment was extracellular. We now report utilization of introducedN-glycosylation sites, NX(S/T), at positions Ser128 in E1, and Gln140, Ileu143, and Phe147 in the H5 sequence of a strong inwardly rectifying K+ channel, Kir2.1. Furthermore, we show that biotinylated channel proteins with N-linked oligosaccharides attached at positions 140 and 143 in the signature sequence are located at the cell surface. Mutant channels were functional as detected by whole-cell and single-channel recordings. Unlike Kir1.1, position Lys117 was not occupied. We conclude that, for yet another K+ channel, the invariant G(Y/F)G sequence is extracellular rather than intramembranous.

14 October 2005 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
CGClaude V. Gallant
Claude V. Gallant
CDCraig Daniels
Craig Daniels
JLJacqueline M. Leung
Jacqueline M. Leung
AGAnindya S. Ghosh
Anindya S. Ghosh
KYKevin D. Young
Kevin D. Young
LBLori L. Burrows
Lori L. Burrows
Summary: β‐Lactamases, which evolved from bacterial penicillin‐binding proteins (PBPs) involved in peptidoglycan (PG) synthesis, confer resistance to β‐lactam antibiotics. While investigating the genetic basis of biofilm development by Pseudomonas aeruginosa, we noted that plasmid vectors encoding the common β‐lactamase marker TEM‐1 caused defects in twitching motility (mediated by type IV pili), adherence and biofilm formation without affecting growth rates. Similarly, strains of Escherichia coli carrying TEM‐1‐encoding vectors grew normally but showed reduced adherence and biofilm formation, showing this effect was not species‐specific. Introduction of otherwise identical plasmid vectors carrying tetracycline or gentamicin resistance markers had no effect on biofilm formation or twitching motility. The effect is restricted to class A and D enzymes, because expression of the class D Oxa‐3 β‐lactamase, but not class B or C β‐lactamases, impaired biofilm formation by E. coli and P. aeruginosa. Site‐directed mutagenesis of the catalytic Ser of TEM‐1, but not Oxa‐3, abolished the biofilm defect, while disruption of either TEM‐1 or Oxa‐3 expression restored wild‐type levels of biofilm formation. We hypothesized that the A and D classes of β‐lactamases, which are related to low molecular weight (LMW) PBPs, may sequester or alter the PG substrates of such enzymes and interfere with normal cell wall turnover. In support of this hypothesis, deletion of the E. coli LMW PBPs 4, 5 and 7 or combinations thereof, resulted in cumulative defects in biofilm formation, similar to those seen in β‐lactamase‐expressing transformants. Our results imply that horizontal acquisition of β‐lactamase resistance enzymes can have a phenotypic cost to bacteria by reducing their ability to form biofilms. β‐Lactamases likely affect PG remodelling, manifesting as perturbation of structures involved in bacterial adhesion that are required to initiate biofilm formation.

1 April 2020 in Anesthesiology
Verified
Journal Article
Closed access
AGAkash Goel
Akash Goel
BMBrandon McGuinness
Brandon McGuinness
NJNaheed K. Jivraj
Naheed K. Jivraj
DWDuminda N. Wijeysundera
Duminda N. Wijeysundera
MMMurray A. Mittleman
Murray A. Mittleman
KLKarim S. Ladha
Karim S. Ladha
Background: Although cannabis is known to have cardiovascular and psychoactive effects, the implications of its use before surgery are currently unknown. The objective of the present study was to determine whether patients with an active cannabis use disorder have an elevated risk of postoperative complications. Methods: The authors conducted a retrospective population-based cohort study of patients undergoing elective surgery in the United States using the Nationwide Inpatient Sample from 2006 to 2015. A sample of 4,186,622 inpatients 18 to 65 yr of age presenting for 1 of 11 elective surgeries including total knee replacement, total hip replacement, coronary artery bypass graft, caesarian section, cholecystectomy, colectomy, hysterectomy, breast surgery, hernia repair, laminectomy, and other spine surgeries was selected. The principal exposure was an active cannabis use disorder, as defined by International Classification of Diseases, Ninth Edition, Clinical Modification (ICD-9-CM) diagnostic codes for cannabis dependence and cannabis abuse. The primary outcome was a composite endpoint of in-hospital postoperative myocardial infarction, stroke, sepsis, deep vein thrombosis, pulmonary embolus, acute kidney injury requiring dialysis, respiratory failure, and in-hospital mortality. Secondary outcomes included hospital length of stay, total hospital costs, and the individual components of the composite endpoint. Results: The propensity-score matched-pairs cohort consisted of 27,206 patients. There was no statistically significant difference between patients with (400 of 13,603; 2.9%) and without (415 of 13,603; 3.1%) a reported active cannabis use disorder with regard to the composite perioperative outcome (unadjusted odds ratio = 1.29; 95% CI, 1.17 to 1.42; P < 0.001; Adjusted odds ratio = 0.97; 95% CI, 0.84 to 1.11; P = 0.63). However, the adjusted odds of postoperative myocardial infarction was 1.88 (95% CI, 1.31 to 2.69; P < 0.001) times higher for patients with a reported active cannabis use disorder (89 of 13,603; 0.7%) compared with those without (46 of 13,603; 0.3%) an active cannabis use disorder (unadjusted odds ratio = 2.88; 95% CI, 2.34 to 3.55; P < 0.001). Conclusions: An active cannabis use disorder is associated with an increased perioperative risk of myocardial infarction. Editor’s Perspective: What We Already Know about This Topic: What This Article Tells Us That Is New: